{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:02:07Z","timestamp":1789660927359,"version":"4.0.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-02231-6","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:37:44Z","timestamp":1789652264000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of BTLA in ovarian cancer and its clinical prognostic significance based on multi-omics analysis"],"prefix":"10.1186","volume":"19","author":[{"given":"Yiliminuer","family":"Abulajiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4828-8408","authenticated-orcid":false,"given":"Yumei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"issue":"12","key":"2231_CR1","first-page":"e33092","volume":"14","author":"NH Farag","year":"2022","unstructured":"Farag NH, Alsaggaf ZH, Bamardouf NO, Khesfaty DM, Fatani MM, Alghamdi MK, et al. The histopathological patterns of ovarian neoplasms in different age groups: a retrospective study in a tertiary care center. Cureus. 2022;14(12):e33092.","journal-title":"Cureus"},{"issue":"1","key":"2231_CR2","first-page":"e77574","volume":"17","author":"J Ramakrishnan","year":"2025","unstructured":"Ramakrishnan J, Singh MN, Paul B, Puthen Parambath S. Clinicopathological analysis of ovarian neoplasms at a tertiary care teaching institute of North Malabar: a four-year retrospective study. Cureus. 2025;17(1):e77574.","journal-title":"Cureus"},{"issue":"4","key":"2231_CR3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.30699\/ijp.2020.104017.2052","volume":"15","author":"F Nazari","year":"2020","unstructured":"Nazari F, Dehghani Z. Coexistence of benign brenner tumor with mucinous cystadenoma in an ovarian mass. Iran J Pathol. 2020;15(4):334\u20137.","journal-title":"Iran J Pathol"},{"key":"2231_CR4","doi-asserted-by":"publisher","first-page":"654960","DOI":"10.3389\/fimmu.2021.654960","volume":"12","author":"Z Ning","year":"2021","unstructured":"Ning Z, Liu K, Xiong H. Roles of BTLA in immunity and immune disorders. Front Immunol. 2021;12:654960.","journal-title":"Front Immunol"},{"key":"2231_CR5","doi-asserted-by":"publisher","first-page":"115161","DOI":"10.1016\/j.biopha.2023.115161","volume":"165","author":"K Kuncewicz","year":"2023","unstructured":"Kuncewicz K, Bojko M, Battin C, Karczy ESA, Sieradzan A, Sikorska E, et al. BTLA-derived peptides as inhibitors of BTLA\/HVEM complex formation - design, synthesis and biological evaluation. Biomedic Pharmacother. 2023;165:115161.","journal-title":"Biomedic Pharmacother"},{"issue":"9","key":"2231_CR6","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1016\/j.apsb.2024.05.032","volume":"14","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhou Q, Jia Z, Cheng N, Zhang S, Chen W, et al. Enhancing cancer immunotherapy: nanotechnology-mediated immunotherapy overcoming immunosuppression. Acta Pharm Sin B. 2024;14(9):3834\u201354.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"2231_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1148\/rg.2021200086","volume":"41","author":"EC Taylor","year":"2021","unstructured":"Taylor EC, Irshaid L, Mathur M. Multimodality imaging approach to ovarian neoplasms with pathologic correlation. Radiographics. 2021;41(1):289\u2013315.","journal-title":"Radiographics"},{"key":"2231_CR8","doi-asserted-by":"publisher","first-page":"956694","DOI":"10.3389\/fimmu.2022.956694","volume":"13","author":"C Battin","year":"2022","unstructured":"Battin C, Leitner J, Waidhofer SCLP, Grabmeier-Pfistershammer K, Olive D, Steinberger P. BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM. Front Immunol. 2022;13:956694.","journal-title":"Front Immunol"},{"key":"2231_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fmolb.2020.00148","volume":"7","author":"J Song","year":"2020","unstructured":"Song J, Wu L. Friend or foe: prognostic and immunotherapy roles of BTLA in colorectal cancer. Front Mol Biosci. 2020;7:148.","journal-title":"Front Mol Biosci"},{"issue":"24","key":"2231_CR10","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.3390\/cells11244021","volume":"11","author":"TY Cheng","year":"2022","unstructured":"Cheng TY, Liu YJ, Yan H, Xi YB, Duan LQ, Wang Y, et al. Tumor cell-intrinsic BTLA receptor inhibits the proliferation of tumor cells via ERK1\/2. Cells. 2022;11(24):4021.","journal-title":"Cells"},{"issue":"8","key":"2231_CR11","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2231_CR12","first-page":"675","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M. Visualizing and interpreting cancer genomics data via the Xena platform. 2020;38(6):675\u20138.","journal-title":"Visualizing and interpreting cancer genomics data via the Xena platform"},{"issue":"7","key":"2231_CR13","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2231_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1089\/bio.2015.29031.hmm","volume":"13","author":"LJ Carithers","year":"2015","unstructured":"Carithers LJ, Moore HM. The Genotype-Tissue Expression (GTEx) project. Biopreserv Biobank. 2015;13(5):307\u20138.","journal-title":"Biopreserv Biobank"},{"key":"2231_CR15","doi-asserted-by":"publisher","first-page":"e19489","DOI":"10.7717\/peerj.19489","volume":"13","author":"X Deng","year":"2025","unstructured":"Deng X, Thompson J. An R package for survival-based gene set enrichment analysis. PeerJ. 2025;13:e19489.","journal-title":"PeerJ"},{"key":"2231_CR16","doi-asserted-by":"publisher","first-page":"8201079","DOI":"10.1155\/2019\/8201079","volume":"2019","author":"T Tataranni","year":"2019","unstructured":"Tataranni T, Piccoli C. Dichloroacetate (DCA) and cancer: an overview towards clinical applications. Oxid Med Cell Longev. 2019;2019:8201079.","journal-title":"Oxid Med Cell Longev"},{"issue":"43","key":"2231_CR17","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2231_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd CTH, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"key":"2231_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7.","journal-title":"BMC Bioinform"},{"issue":"D1","key":"2231_CR20","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607-d613.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2231_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/nar\/27.1.29","volume":"27","author":"H Ogata","year":"1999","unstructured":"Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999;27(1):29\u201334.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2231_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"23","key":"2231_CR23","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","volume":"83","author":"I de Bruijn","year":"2023","unstructured":"de Bruijn I, Kundra R, Mastrogiacomo B, Tran TN, Sikina L, Mazor T, et al. Analysis and visualization of longitudinal genomic and clinical data from the AACR Project GENIE Biopharma Collaborative in cBioPortal. Cancer Res. 2023;83(23):3861\u20137.","journal-title":"Cancer Res"},{"issue":"Database issue","key":"2231_CR24","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Database issue):D92-97.","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"2231_CR25","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184(13):3573-3587.e3529.","journal-title":"Cell"},{"key":"2231_CR26","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1016\/j.csbj.2021.06.043","volume":"19","author":"M Andreatta","year":"2021","unstructured":"Andreatta M, Carmona SJ. UCell: robust and scalable single-cell gene signature scoring. Comput Struct Biotechnol J. 2021;19:3796\u20138.","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"2231_CR27","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12(1):1088.","journal-title":"Nat Commun"},{"issue":"Database issue","key":"2231_CR28","first-page":"D955","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, et al. Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41(Database issue):D955-961.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2231_CR29","doi-asserted-by":"publisher","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","volume":"22","author":"D Maeser","year":"2021","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021;22(6):bbab260.","journal-title":"Brief Bioinform"},{"issue":"D1","key":"2231_CR30","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","volume":"49","author":"S Kim","year":"2021","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, et al. PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res. 2021;49(D1):D1388-d1395.","journal-title":"Nucleic Acids Res"},{"key":"2231_CR31","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/978-1-4939-7000-1_26","volume":"1607","author":"SK Burley","year":"2017","unstructured":"Burley SK, Berman HM, Kleywegt GJ, Markley JL, Nakamura H, Velankar S. Protein Data Bank (PDB): the single global macromolecular structure archive. Methods Mol Biol. 2017;1607:627\u201341.","journal-title":"Methods Mol Biol"},{"issue":"W1","key":"2231_CR32","doi-asserted-by":"publisher","first-page":"W159","DOI":"10.1093\/nar\/gkac394","volume":"50","author":"Y Liu","year":"2022","unstructured":"Liu Y, Yang X, Gan J, Chen S, Xiao ZX, Cao Y. CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic Acids Res. 2022;50(W1):W159-w164.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"2231_CR33","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings. J Chem Inf Model. 2021;61(8):3891\u20138.","journal-title":"J Chem Inf Model"},{"issue":"1","key":"2231_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13048-024-01507-z","volume":"17","author":"P Kaur","year":"2024","unstructured":"Kaur P, Singh SK, Mishra MK, Singh S, Singh R. Nanotechnology for boosting ovarian cancer immunotherapy. J Ovarian Res. 2024;17(1):202.","journal-title":"J Ovarian Res"},{"issue":"9","key":"2231_CR35","first-page":"4671","volume":"24","author":"RR Zhang","year":"2020","unstructured":"Zhang RR, Wang LM, Shen JJ. Overexpression of miR-32 inhibits the proliferation and metastasis of ovarian cancer cells by targeting BTLA. Eur Rev Med Pharmacol Sci. 2020;24(9):4671\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"2231_CR36","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/diagnostics12020251","volume":"12","author":"J \u015awiderska","year":"2022","unstructured":"\u015awiderska J, Koz\u0142owski M, Gaur M, Pius-Sadowska E, Kwiatkowski S, Machali\u0144ski B, et al. Clinical Significance of BTLA, CD27, CD70, CD28 and CD80 as Diagnostic and Prognostic Markers in Ovarian Cancer. Diagnostics (Basel). 2022;12(2):251.","journal-title":"Diagnostics (Basel)"},{"key":"2231_CR37","doi-asserted-by":"publisher","first-page":"156412","DOI":"10.1016\/j.cyto.2023.156412","volume":"172","author":"AH Mohamed","year":"2023","unstructured":"Mohamed AH, Obeid RA, Fadhil AA, Amir AA, Adhab ZH, Jabouri EA, et al. BTLA and HVEM: emerging players in the tumor microenvironment and cancer progression. Cytokine. 2023;172:156412.","journal-title":"Cytokine"},{"key":"2231_CR38","doi-asserted-by":"publisher","first-page":"116231","DOI":"10.1016\/j.ejmech.2024.116231","volume":"268","author":"K Wojciechowicz","year":"2024","unstructured":"Wojciechowicz K, Spodzieja M, Wardowska A. The BTLA-HVEM complex - the future of cancer immunotherapy. Eur J Med Chem. 2024;268:116231.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"2231_CR39","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s12885-023-10911-5","volume":"23","author":"D Fanale","year":"2023","unstructured":"Fanale D, et al. Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer. BMC Cancer. 2023;23(1):437.","journal-title":"BMC Cancer"},{"issue":"9","key":"2231_CR40","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3390\/ph18091295","volume":"18","author":"YL Lai","year":"2025","unstructured":"Lai YL, Lin HW, Huang YW, Chen J, Tai MC, Wu CY, et al. Analysis of immune checkpoints on peripheral blood mononuclear cells can predict clinical outcome and reveal potential of HVEM-BTLA axis in epithelial ovarian cancers. Pharmaceuticals (Basel). 2025;18(9):1295.","journal-title":"Pharmaceuticals (Basel)"},{"key":"2231_CR41","doi-asserted-by":"publisher","first-page":"e2500304","DOI":"10.1200\/PO-25-00304","volume":"9","author":"D Nishizaki","year":"2025","unstructured":"Nishizaki D, Choi S, Pandya C, Lee S, Pabla S, DePietro P, et al. Pan-cancer landscape of B- and T-lymphocyte attenuator: implications for potential immunotherapy combinations. JCO Precis Oncol. 2025;9:e2500304.","journal-title":"JCO Precis Oncol"},{"issue":"2","key":"2231_CR42","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3390\/ijms21020636","volume":"21","author":"M Spodzieja","year":"2020","unstructured":"Spodzieja M, Kuncewicz K, Sieradzan A, Karczy\u0144ska A, Iwaszkiewicz J, Cesson V, et al. Disulfide-Linked Peptides for Blocking BTLA\/HVEM Binding. Int J Mol Sci. 2020;21(2):636.","journal-title":"Int J Mol Sci"},{"key":"2231_CR43","doi-asserted-by":"publisher","first-page":"151883","DOI":"10.1016\/j.anndiagpath.2021.151883","volume":"57","author":"J Huang","year":"2022","unstructured":"Huang J, Mao Q, Sun X. Identification of a DNA repair 9-gene signature for the overall survival prediction of pancreatic cancer. Ann Diagn Pathol. 2022;57:151883.","journal-title":"Ann Diagn Pathol"},{"issue":"10","key":"2231_CR44","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1080\/15257770.2023.2296615","volume":"43","author":"X Gao","year":"2024","unstructured":"Gao X, Gao Y, Pan S, Yang L. Clinical significance of BTLA gene expression and rs1982809 polymorphism in pan-cancer. Nucleosides Nucleotides Nucleic Acids. 2024;43(10):1065\u201376.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"2231_CR45","first-page":"7545666","volume":"2022","author":"Z Wang","year":"2022","unstructured":"Wang Z, Rehman AU, Qin X, Zhu C, Wu S. PI3K\/AKT\/mTOR pathway-associated genes reveal a putative prognostic signature correlated with immune infiltration in hepatocellular carcinoma. Dis Markers. 2022;2022:7545666.","journal-title":"Dis Markers"},{"key":"2231_CR46","doi-asserted-by":"publisher","first-page":"946319","DOI":"10.3389\/fonc.2022.946319","volume":"12","author":"D Fanale","year":"2022","unstructured":"Fanale D, Corsini LR, Brando C, Cutaia S, Di Donna MC, Filorizzo C, et al. Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer? Front Oncol. 2022;12:946319.","journal-title":"Front Oncol"},{"issue":"1","key":"2231_CR47","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s12672-025-03356-8","volume":"16","author":"T Lei","year":"2025","unstructured":"Lei T, Jiang Y, Yang K, Meng C, An Y. Meta_B cells: a computationally identified candidate immunosuppressive driver of gastric cancer metastasis revealed by single-cell analysis and machine learning. Discov Oncol. 2025;16(1):1485.","journal-title":"Discov Oncol"},{"issue":"2","key":"2231_CR48","first-page":"10224","volume":"9","author":"AA Tarhini","year":"2024","unstructured":"Tarhini AA, Hedges D, Tan AC, Rodriguez P, Sukrithan V, Ratan A, et al. Differences in co-expression of T cell co-inhibitory and co-stimulatory molecules with PD-1 across different human cancers. J Oncol Res Ther. 2024;9(2):10224.","journal-title":"J Oncol Res Ther"},{"issue":"3","key":"2231_CR49","doi-asserted-by":"publisher","first-page":"e70276","DOI":"10.1002\/ctm2.70276","volume":"15","author":"Y Liu","year":"2025","unstructured":"Liu Y, Yan C, Li Y, Zhou R, Lin X, Meng Q, et al. Single-cell RNA sequencing of peripheral blood mononuclear cells from bronchopulmonary dysplasia. Clin Transl Med. 2025;15(3):e70276.","journal-title":"Clin Transl Med"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02231-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02231-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02231-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:02:44Z","timestamp":1789657364000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02231-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2231"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02231-6","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"13 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of Beijing Obstetrics and Gynecology Hospital (Approval No.: 2022-KY-092-01). All procedures were conducted in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments. Registry and the Registration No. of the study\/trial: N\/A;Animal Studies: N\/A.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have consented to publication of this research.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"288"}}